Alaunos Therapeutics | تكلفة المبيعات



Cost Of Sales تغيير تاريخ
Adcock Ingram Holdings ZAR 3.18B 115.21M 2024-12
Alaunos Therapeutics 0 18K 2024-09
Amgen USD 2.6B 507M 2025-03
AstraZeneca USD 2.24B 484M 2025-03
Baxter International USD 1.74B 73M 2024-12
Biogen USD 629.3M 45.8M 2025-03
Bioline Rx USD 822K 75K 2024-09
Bristol-Myers Squibb USD 3.03B 179M 2025-03
Celltrion KRW 399.04B 297.8B 2025-03
Corcept Therapeutics USD 2.4M 553K 2025-03
Cspc Pharmaceutical CNY 2.07B 71.26M 2024-09
Divis Laboratories Ltd 9.81B 590M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
GlaxoSmithKline GBP 1.92B 635M 2025-03
Incyte USD 67.8M 14.58M 2025-03
Ionis Pharmaceuticals USD 1000K 2.83M 2025-03
J&J USD 7.3B 189M 2025-03
Kangmei Pharma CNY 1.21B 124.7M 2024-09
Knight Therapeutics CAD 47.25M 990K 2024-09
Laboratorios Farma EUR 152.05M 84.2M 2024-12
Malin Corporation EUR 15.4M 0 2020-12
Medical Developments International AUD 2.35M 1.73M 2024-06
Merck USD 2.76B 944M 2025-03
Novartis USD 3.32B 90M 2024-12
Organigram Holdings CAD 41.68M 69.31M 2024-12
Pfizer USD 2.59B 3.06B 2025-03
Pharma Mar EUR 3.4M 2.09M 2025-03
PTC Therapeutics USD 12.86M 3.42M 2025-03
Qiagen NV USD 187.91M 16.67M 2024-12
Regeneron Pharmaceuticals USD 265.5M 299.9M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Sartorius EUR 452M 60.2M 2025-03
Sino Biopharmaceutical CNY 2.49B 1.07B 2024-12
TG Therapeutics USD 15.4M 6.06M 2024-12
Tilray USD 149.73M 9.39M 2024-11
Zz Pientze Pharmaceu 1.73B 158.67M 2025-03



Alaunos Therapeutics تكلفة المبيعات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.